Neoadjuvant Treatment of Locally-advanced Breast Cancer Patients With Ribociclib and Letrozole

NCT05163106 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

85

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
HER2-negative Breast Cancer
ER-positive Breast Cancer
Locally Advanced Breast Cancer
Luminal A Breast Cancer
Luminal B Breast Cancer

Interventions

DRUG: Letrozole 2.5mg oral tablet; Ribociclib 600mg oral tablet
DRUG: Goserelin

Sponsor

University Hospital, Akershus

Collaborators

[object Object]
[object Object]